Skip to content

Clinical application of laparoscopic fluorescence cholangiography in extrahepatic biliary tract operation

Clinical application of laparoscopic fluorescence cholangiography in extrahepatic biliary tract operation

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900028137
Enrollment
Unknown
Registered
2019-12-13
Start date
2019-12-13
Completion date
Unknown
Last updated
2019-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fluorescence cholangiography

Interventions

4 groups:Different injection time of ICG

Sponsors

Guangzhou First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Part one, Criteria for enrolling patients must meet the following requirements: 1. Patients with indwelling T tube for more than 1 month after extrahepatic biliary tract operation; 2. Patient without biliary obstruction; 3. Imaging examination, such as CT or ultrasound, did not report cirrhosis, and the serum billirubin is less than 30 umol/L; 4. Aged >=18 years. Part two, The inclusion criteria were as follows: 1. Patients have the indications of extrahepatic biliary tract operation and requiring using laparoscopy; 2. Serum billirubin is less than 30 umol/L; 3. Imaging examination, such as CT or ultrasound, did not report cirrhosis; 4. Aged >=18 years.

Exclusion criteria

Exclusion criteria: The exclusion criterion is that the patient with a history of adverse reactions or known allergy to ICG, iodine, or iodine dyes.

Design outcomes

Primary

MeasureTime frame
fluorescence intensity ;

Secondary

MeasureTime frame
fluorescence intensity ratio;

Countries

China

Contacts

Public ContactWeili Gu

Guangzhou First People's Hospital

zr517601@163.com+86 13922108036

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026